Phase
Condition
Digestive System Neoplasms
Treatment
Endoscopy
Radiology
Chemotherapy
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Borderline resectable or locally advanced adenocarcinoma of the pancreas (NCCN,version 2, 2021) (Appendix 3)
Nx, M0 (UICC 8th version, 2016)
Cytological or histological confirmation of adenocarcinoma
Age >18 year
Considered able to receive primary chemotherapy and possible surgery
Written informed consent
Exclusion
Exclusion Criteria:
Co-morbidity or performance status precluding primary chemotherapy
Co-morbidity or performance status precluding pancreatectomy
Female patients in child-bearing age not using adequate contraception, pregnant orlactating women
Mental or physical disorders that could interfere with treatment of with theprovision of informed consent
Any reason why, in the opinion of the investigator, the patient should notparticipate
Study Design
Connect with a study center
Haukeland University Hospital
Bergen, 5021
NorwaySite Not Available
Oslo University Hospital
Oslo, 0424
NorwayActive - Recruiting
Stavanger University Hospital
Stavanger, 4068
NorwaySite Not Available
University Hospital of North Norway
Tromsø, 9038
NorwaySite Not Available
St. Olavs Hospital, Trondheim University Hospital
Trondheim, 7006
NorwaySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.